Design Therapeutics, Inc. (DSGN): Price and Financial Metrics
DSGN Price/Volume Stats
| Current price | $4.08 | 52-week high | $7.77 |
| Prev. close | $3.97 | 52-week low | $2.32 |
| Day low | $3.91 | Volume | 135,100 |
| Day high | $4.19 | Avg. volume | 165,957 |
| 50-day MA | $5.40 | Dividend yield | N/A |
| 200-day MA | $4.91 | Market Cap | 231.01M |
DSGN Stock Price Chart Interactive Chart >
Design Therapeutics, Inc. (DSGN) Company Bio
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
DSGN Price Returns
| 1-mo | -19.37% |
| 3-mo | -29.17% |
| 6-mo | -18.56% |
| 1-year | 55.13% |
| 3-year | -71.08% |
| 5-year | N/A |
| YTD | -33.87% |
| 2024 | 132.83% |
| 2023 | -74.17% |
| 2022 | -52.08% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...